A Multi-center RCT Trial on Prognosis of Patients With Anticoagulation and DAPT Therapy After LAAC
Conditions: Left Atrial Appendage Thrombosis; Thrombi; Stroke Interventions: Drug: Rivaroxaban; Drug: DAPT Sponsor: Shanghai Zhongshan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials